Artelo Biosciences Inc (ARTL) Price Prediction & ForecastARTLArtelo Biosciences Inc

Alphio's ARTL stock price prediction model matches the current Artelo Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.98 (+0.31%). The 1-week path is $5.92 (-0.73%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Artelo Biosciences Inc is not a good buy right now due to its poor financial performance and negative market sentiment. The current price is $0.66, which is down 82.61% year-to-date. Additionally, the RSI is at 28.658, indicating that the stock is oversold, but this could also suggest further downward pressure. The company has reported consistent losses, with a net income of -$2,427,000 in Q2 2026 and a forward P/E ratio of 0, reflecting a lack of profitability. The recent announcement of a 1-for-9 reverse stock split has also led to a drop in share price by 2.87%, indicating negative market sentiment. The main risk is the ongoing losses and lack of revenue generation, as evidenced by a price-to-sales ratio of 0 and a price-to-free cash flow of -0.257952, suggesting that the company is not generating cash flow effectively.

Artelo Biosciences Inc (ARTL) last closed at $5.9643, gaining +0.26%. These facts feed the 1-day and 1-week ARTL price prediction above.